Cilostazol and Aspirin in Stroke and TIA

Summary

This study is a randomized, open-labelled trial. We randomly assigned patients within 24 hours after the onset of minor ischemic stroke or high-risk TIA to combination therapy with cilostazol and aspirin or to clopidogrel plus aspirin. The primary outcome was stroke (ischemic or hemorrhagic) during 90 days of follow-up in an intention-to-treat analysis.

Timeline

Start

2019-07-18

Primary completion

2022-10-17

Completion

2022-10-17

Drugs

Indications